Your browser doesn't support javascript.
loading
Incidence and Predictors of Breakthrough and Severe Breakthrough Infections of SARS-CoV-2 After Primary Series Vaccination in Adults: A Population-Based Survey of 22 575 Participants.
DeSantis, Stacia M; Yaseen, Ashraf; Hao, Tianyao; León-Novelo, Luis; Talebi, Yashar; Valerio-Shewmaker, Melissa A; Pinzon Gomez, Cesar L; Messiah, Sarah E; Kohl, Harold W; Kelder, Steven H; Ross, Jessica A; Padilla, Lindsay N; Silberman, Mark; Tuzo, Samantha; Lakey, David; Shuford, Jennifer A; Pont, Stephen J; Boerwinkle, Eric; Swartz, Michael D.
Afiliação
  • DeSantis SM; The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Yaseen A; The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Hao T; The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas, USA.
  • León-Novelo L; The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Talebi Y; The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Valerio-Shewmaker MA; The University of Texas Health Science Center at Houston, School of Public Health in Brownsville, Brownsville, Texas, USA.
  • Pinzon Gomez CL; The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Messiah SE; The University of Texas Health Science Center at Houston, School of Public Health in Dallas, Dallas, Texas, USA.
  • Kohl HW; Center for Pediatric Population Health, University of Texas Health School of Public Health, Dallas, Texas, USA.
  • Kelder SH; The University of Texas Health Science Center at Houston, School of Public Health in Austin, Austin, Texas, USA.
  • Ross JA; Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, Texas, USA.
  • Padilla LN; The University of Texas Health Science Center at Houston, School of Public Health in Austin, Austin, Texas, USA.
  • Silberman M; The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Tuzo S; The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas, USA.
  • Lakey D; Clinical Pathology Laboratories, Austin, Texas, USA.
  • Shuford JA; Clinical Pathology Laboratories, Austin, Texas, USA.
  • Pont SJ; Office of Health Affairs, The University of Texas System, Austin, Texas, USA.
  • Boerwinkle E; The University of Texas at Tyler Health Science Center, Tyler, Texas, USA.
  • Swartz MD; Texas Department of State Health Services, Austin, Texas, USA.
J Infect Dis ; 227(10): 1164-1172, 2023 05 12.
Article em En | MEDLINE | ID: mdl-36729177
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article